.png)
Regis Custom Pharma is a US-based contract development and manufacturing organization (CDMO) focused on the development and manufacture of NCE's (New Chemical Entities). We offer a comprehensive range of drug substance development services to support the development of lead molecules from preclinical through commercialization including Process Chemistry, Analytical Method Development and Validation, Solid State Chemistry, Micronization, cGMP Manufacturing, Process Validation, and Stability Services.
In addition to our extensive API development and manufacturing, we also offer an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicago area since 1956.